Sunesis Pharmaceuticals Inc (SNSS): Cormorant Asset Management Reports New 5.14% Stake

Page 8 of 10

Page 8 of 10 – SEC Filing
CUSIP NO.
867328502
Bihua Chen – 0 shares
(ii)
shared power to vote or to direct the vote
Cormorant Global Healthcare Master Fund, LP – 831,500 shares
Cormorant Global Healthcare GP, LLC – 831,500 shares
Cormorant Asset Management, LLC – 1,000,000 shares
Bihua Chen – 1,000,000 shares
(iii)
sole power to dispose or to direct the disposition of
Cormorant Global Healthcare Master Fund, LP – 0 shares
Cormorant Global Healthcare GP, LLC – 0 shares
Cormorant Asset Management, LLC – 0 shares
Bihua Chen – 0 shares
(iv)
shared power to dispose or to direct the disposition of
Cormorant Global Healthcare Master Fund, LP – 831,500 shares
Cormorant Global Healthcare GP, LLC – 831,500 shares
Cormorant Asset Management, LLC – 1,000,000 shares
Bihua Chen – 1,000,000 shares
*** Shares reported herein for Cormorant Asset Management, LLC represent shares which are beneficially owned by Cormorant Global Healthcare Master Fund, LP (the “Fund”), as reported herein, and shares which are beneficially owned by a managed account  (the “Account”). Cormorant Global Healthcare GP, LLC serves as the general partner of the Fund, and Cormorant Asset Management, LLC serves as the investment manager to both the Fund and the Account.  Bihua Chen serves as the managing member of Cormorant Global Healthcare GP, LLC and Cormorant Asset Management, LLC.  Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein.
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [  ].
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
Not applicable.

Follow Viracta Therapeutics Inc. (NASDAQ:VIRX)

Page 8 of 10